Related Experiment Video

Updated: Jan 23, 2026

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:18

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

10.2K

MicroRNAs in juvenile idiopathic arthritis: Can we learn more about pathophysiological mechanisms?

Nadege Nziza1, Isabelle Duroux-Richard2, Florence Apparailly3

  • 1IRMB, INSERM, University of Montpellier, Montpellier, France; Arthritis R&D, Neuilly sur Seine, France.

Autoimmunity Reviews
|June 10, 2019
PubMed

Insights

MicroRNAs (miRNAs) show altered expression in juvenile idiopathic arthritis (JIA), a complex childhood condition. Studying these small RNAs may reveal new biomarkers for JIA diagnosis, activity, and progression.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • Juvenile idiopathic arthritis (JIA) is a chronic, multifactorial autoimmune condition affecting children under 16.
  • The underlying pathogenesis and distinct subtypes of JIA remain poorly understood, complicating diagnosis and treatment.
  • MicroRNAs (miRNAs), small non-coding RNAs, are crucial regulators of immune responses and their dysregulation is linked to autoimmune diseases.

Purpose of the Study:

  • To review and synthesize published data on miRNA expression profiles in JIA patients.
  • To identify potential miRNA biomarkers for JIA diagnosis, disease activity, and progression.
  • To explore common pathophysiological pathways in different JIA subtypes through miRNA analysis.

Main Methods:

  • Systematic review of studies reporting miRNA expression in JIA patients.
  • Analysis of miRNA expression data across various JIA subtypes.
  • Correlation of miRNA dysregulation with clinical parameters of JIA.

Main Results:

  • Specific miRNA expression profiles are associated with JIA.
  • Certain miRNAs may serve as diagnostic biomarkers for JIA.
  • MiRNA dysregulation offers insights into JIA pathogenesis and potential therapeutic targets.

Conclusions:

  • MiRNAs represent promising biomarkers for JIA diagnosis and monitoring.
  • Further research into miRNA function can elucidate JIA pathophysiology.
  • Targeting miRNAs may offer novel therapeutic strategies for JIA.

More Related Videos

Inducing the Entry of Third Stage Dispersal Juveniles of Bursaphelenchus xylophilus into Cryptobiosis Through Osmotic Regulation05:15

Inducing the Entry of Third Stage Dispersal Juveniles of Bursaphelenchus xylophilus into Cryptobiosis Through Osmotic Regulation

Published on: December 27, 2024

708
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.9K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
2.9K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.2K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.4K